Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Makoto, Tanikawa"'
Autor:
Akira Kanamori, Seiki Kiriyama, Makoto Tanikawa, Yasuhiro Hisanaga, Hidenori Toyoda, Toshifumi Tada, Syusuke Kitabatake, Yuji Kaneoka, Atsuyuki Maeda, Takashi Kumada
Publikováno v:
Endoscopy International Open, Vol 04, Iss 01, Pp E83-E90 (2016)
Backgrounds and study aims: Endoscopic sphincterotomy (ES) is widely accepted as first-line therapy for bile duct stones (BDS). The major long-term pancreaticobiliary complication is BDS recurrence. Whether cholecystectomy should be performed after E
Externí odkaz:
https://doaj.org/article/4132beee274a47449ec0c0b28b12911e
Autor:
Yasuhiro Hisanaga, Shusuke Kitabatake, Hidenori Toyoda, Satoshi Yasuda, Makoto Tanikawa, Akira Kanamori, Shohei Shiota, Takashi Kumada, Yoshio Sumida, Seiki Kiriyama, Takahiro Koyabu, Daiju Furukawa, Manabu Furoi, Satoshi Yamamoto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::25e583826f84764bd3ae50f7d1728300
https://doi.org/10.1002/ygh2.418/v2/response1
https://doi.org/10.1002/ygh2.418/v2/response1
Autor:
Shusuke Kitabatake, Seiki Kiriyama, Yasuhiro Hisanaga, Junko Tanaka, Akira Kanamori, Makoto Tanikawa, Takashi Kumada, Tsuyoki Yama, Toshifumi Tada, Hidenori Toyoda
Publikováno v:
Journal of Gastroenterology and Hepatology. 32:687-694
Background and Aim Eradication of hepatitis C virus (HCV) with interferon (IFN)-based therapy has been reported to reduce all-cause mortality in patients with chronic HCV infection. However, the impact of HCV eradication on non–liver-related mortal
Autor:
Natsuko Kobayashi, Kazuyuki Mizuno, Akira Takeda, Takashi Kumada, Seiki Kiriyama, Takafumi Tada, Hidenori Toyoda, Ryo Higashibori, Tsuyoki Yama, Makoto Tanikawa
Publikováno v:
Kanzo. 58:379-385
Autor:
Shusuke Kitabatake, Yasuhiro Hisanaga, Junko Tanaka, Makoto Tanikawa, Seiki Kiriyama, Akira Kanamori, Hidenori Toyoda, Takashi Kumada, Tsuyoki Yama, Toshifumi Tada
Publikováno v:
Hepatology Research. 47:1021-1031
Aim The rate of hepatocellular carcinoma (HCC) development is reportedly lower in patients with chronic hepatitis C virus (HCV) who have achieved a sustained virological response (SVR) than in patients who were unresponsive to therapy. However, the d
Autor:
Syusuke Kitabatake, Seiki Kiriyama, Hidenori Toyoda, Yasuhiro Hisanaga, Yuji Kaneoka, Atsuyuki Maeda, Makoto Tanikawa, Toshifumi Tada, Akira Kanamori, Takashi Kumada
Publikováno v:
Endoscopy International Open
Endoscopy International Open, Vol 04, Iss 01, Pp E83-E90 (2016)
Endoscopy International Open, Vol 04, Iss 01, Pp E83-E90 (2016)
Backgrounds and study aims: Endoscopic sphincterotomy (ES) is widely accepted as first-line therapy for bile duct stones (BDS). The major long-term pancreaticobiliary complication is BDS recurrence. Whether cholecystectomy should be performed after E
Autor:
Yasuhiro Hisanaga, Toshifumi Tada, Shusuke Kitabatake, Akira Kanamori, Takashi Kumada, Tsuyoki Yama, Makoto Tanikawa, Seiki Kiriyama, Hidenori Toyoda
Publikováno v:
Journal of Gastroenterology and Hepatology. 30:1412-1419
Background and Aim It has been reported that the branched-chain amino acid (BCAA) to tyrosine ratio (BTR) is a useful indicator of liver function and BCAA therapy is associated with a decreased incidence of hepatocellular carcinoma (HCC). However, th
Autor:
Takanori Ito, Shusuke Kitabatake, Takashi Kumada, Toshifumi Tada, Yasuhiro Hisanaga, Makoto Tanikawa, Seiki Kiriyama, Akira Kanamori, Hidenori Toyoda
Publikováno v:
Journal of Viral Hepatitis. 22:777-783
The FIB-4 index is a simple formula using age, aspartate aminotransferase, alanine aminotransferase (ALT) and platelet count to evaluate liver fibrosis. We investigated the ability of the FIB-4 index for hepatocarcinogenesis in hepatitis C virus (HCV
Autor:
Shinji Satomura, Makoto Tanikawa, Takashi Kumada, Junko Tanaka, Chiaki Kagebayashi, Hidenori Toyoda, Seiki Kiriyama, Akira Kanamori, Toshifumi Tada, Yasuhiro Hisanaga
Publikováno v:
Journal of Gastroenterology
Background Prognosis of patients with hepatocellular carcinoma (HCC) remains poor because HCC is frequently diagnosed late. Therefore, regular surveillance has been recommended to detect HCC at the early stage when curative treatments can be applied.
Autor:
Takashi Kumada, Yoshiki Murakami, Toshifumi Tada, Makoto Tanikawa, Shusuke Kitabatake, Akira Kanamori, Yasuhiro Hisanaga, Hidenori Toyoda, Seiki Kiriyama
Publikováno v:
Cytokine. 63:145-150
Backgrounds/aims We investigated the association between hepatic steatosis and hepatic expression of genes involved in innate immunity, both of which are reportedly associated with resistance to peginterferon (PEG-IFN) and ribavirin combination thera